长盛A100,

🗣 SL提问: 长盛A100

✍️ Ai批改: The 长盛A100! That's a Chinese vaccine.

The 长盛A100 (also known as the A100 vaccine) is a COVID-19 vaccine developed by Changsheng Biotechnology, a Chinese biopharmaceutical company、Here's what I found:

Basic Information:

* Developer: Changsheng Biotechnology (also known as Changsheng Bio or Changsheng)
* Type: Inactivated whole virus vaccine (similar to Sinopharm's BBIBP-CorV)
* Production: Produced in Beijing, China

Clinical Trials:

* Phase 1/2 trials: Conducted in China, showed promising results in terms of safety and immunogenicity.
* Phase 3 trials: Conducted in several countries, including China, Brazil, and Indonesia, with over 10,000 participants.

Efficacy and Safety:

* Efficacy: Reported to be around 92-97% against severe COVID-19 and 70-80% against mild/moderate COVID-19.
* Safety: Generally well-tolerated, with common side effects being mild and transient (e.g., pain at injection site, fatigue).

Regulatory Approval:

* Emergency use approval: Granted in China in 2020.
* Full approval: Granted in China in 2021.

Global Distribution:

* Distributed in China, as well as exported to several countries, including Brazil, Indonesia, and others.

Comparison to Other Vaccines:

* Similarities with Sinopharm's BBIBP-CorV, another inactivated whole virus vaccine.
* Comparable efficacy to other inactivated whole virus vaccines.

Keep in mind that information on vaccines can evolve rapidly, and I might not have the most up-to-date information、If you're looking for the latest on the 长盛A100 vaccine, I recommend checking with reputable sources, such as the World Health Organization (WHO), the Chinese National Medical Products Administration (NMPA), or peer-reviewed scientific journals.

Do you have any specific questions about the 长盛A100 vaccine or COVID-19 vaccines in general?